Despite uncertainty and concern buffeting Massachusetts hospitals, the state’s largest health system saw its finances improve ...

A vaccine adviser at the CDC with ties to health secretary Robert F. Kennedy Jr. is being given a new portfolio overseeing ...

Two government officials told STAT that the White House has been involved in final decisions about the FDA's new priority ...

The Trump administration intends to make its most forceful attempt yet at restricting gender-affirming care for transgender ...

BioMarin's new CEO had promised Wall Street there would be deals, and with Amicus, it has one the market likes.

It took 27 years, but Cytokinetics secured its first U.S. drug approval. On Friday, the Food and Drug Administration cleared ...

UnitedHealth Group said Friday that the consultants it hired to audit its operations found they’re not only “robust,” but ...

The U.K. government wants to boost the local life sciences industry, and it hopes to entice American venture capital firms to ...

With its vaccine schedule, “Denmark has made a values choice to accept preventable hospitalizations and illnesses that other ...

Nine drugmakers are set to unveil deals with the Trump administration to lower the prices of some of their drugs, marking the ...

The New York Times once called John Lamattina, then Pfizer head of R&D, “Dr. Optimistic.” He’s not so optimistic now.

The award is in response to an “unsolicited proposal,” according to documents in the Federal Register. The University of ...